|
RBM22 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.69159999954915E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.3442000001973E-07 |
| Normal-vs-Stage2 |
9.284200E-03 |
| Normal-vs-Stage3 |
6.892400E-02 |
| Normal-vs-Stage4 |
9.728400E-01 |
| Stage1-vs-Stage2 |
7.308600E-01 |
| Stage1-vs-Stage3 |
1.257400E-01 |
| Stage1-vs-Stage4 |
3.251900E-02 |
| Stage2-vs-Stage3 |
4.065000E-01 |
| Stage2-vs-Stage4 |
1.352840E-01 |
| Stage3-vs-Stage4 |
3.364600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.7728000001902E-07 |
| Normal-vs-AfricanAmerican |
6.34219999999797E-05 |
| Normal-vs-Asian |
5.431800E-01 |
| Caucasian-vs-AfricanAmerican |
8.460000E-01 |
| Caucasian-vs-Asian |
3.889600E-01 |
| AfricanAmerican-vs-Asian |
3.823600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.27089999635288E-08 |
| Normal-vs-Female |
2.582500E-02 |
| Male-vs-Female |
3.436600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.040300E-03 |
| Normal-vs-Extreme_Weight |
1.2011000000145E-06 |
| Normal-vs-Obese |
2.204600E-04 |
| Normal-vs-Extreme_Obese |
4.71359999998366E-06 |
| Normal_Weight-vs-Extreme_Weight |
4.295800E-01 |
| Normal_Weight-vs-Obese |
9.345000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.435970E-01 |
| Extreme_Weight-vs-Obese |
3.055600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.799200E-01 |
| Obese-vs-Extreme_Obese |
7.942400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.745500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.338850E-03 |
| Normal-vs-Age(61-80Yrs) |
2.77489997646541E-09 |
| Normal-vs-Age(81-100Yrs) |
8.675100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.032000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.239600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.988830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.182800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.987800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.429600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.1101000098086E-09 |
| Normal-VS-Type2 PRCC |
1.000510E-03 |
| Normal-VS-KIRP CIMP |
2.014100E-02 |
| Normal-VS-Unclassified PRCC |
2.784400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.059560E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.567200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.007800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.219800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.640000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.933400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.84699999961069E-07 |
| Normal-vs-N1 |
9.963200E-01 |
| Normal-vs-N2 |
1.327610E-01 |
| N0-vs-N1 |
4.380200E-03 |
| N0-vs-N2 |
3.762400E-01 |
| N1-vs-N2 |
4.759800E-01 |
|
|
